HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress


$171.4 million of cash, cash equivalents and marketable securities as of December 31, 2024

More:
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress

Related Posts